Clinical Trials Logo

Clinical Trial Summary

The main objective of this study is to evaluate the prevalence and the clinical impact of Orthohepevirus C infection in different human populations, and to determine its zoonotic origin comparing the sequences obtained in both human and animal populations. This is an ambispective study where Orthohepevirus C infection will be evaluated in four high risk human population: i) patients with acute hepatitis, ii) patients with positive IgM antibody against Hepatitis E virus infection with undetectable viral load, iii) HIV infected individuals, and iv) solid organ transplant recipients. Furthermore, we will analyze three animal populations: i) suburban rodents, ii) domestic rodents, iii) wild carnivores. Viral sequences identified in both human and animal populations will be compared to evaluate the zoonotic origin of the infections.


Clinical Trial Description

To carry out the project a database will be created in electronic format, where the study team will integrate epidemiological, clinical and laboratory tests data of patients. Data will be anonymous and coded by a data manager. Primary objective is to assess the prevalence of Ortho-C infection in patients with acute hepatitis of no identified origin Secondary objectives are: 1. To evaluate the prevalence and risk factors of Ortho-C infection in patients with solid organ transplant. 2. To evaluate the prevalence and risk factors of Ortho-C infection in patients with HIV infection. 3. To assess the presence of Ortho-C infection in patients with the presence of antibodies (IgM) against HEV and absence of HEV-RNA 4. To evaluate the prevalence of infection by Ortho-C in wild and periurban rodents. 5. To evaluate the prevalence of infection by Ortho-C in domestic rodents and mustelids. 6. To evaluate the prevalence of infection by Ortho-C in wild carnivores 7. To molecularly characterize and evaluate the degree of homology of Ortho-C viral sequences found in humans and animals ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05062967
Study type Observational [Patient Registry]
Source Maimónides Biomedical Research Institute of Córdoba
Contact ANTONIO RIVERO ROMÁN
Phone 957012421
Email [email protected]
Status Not yet recruiting
Phase
Start date January 1, 2022
Completion date December 1, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04825470 - Liver Transplantation for Unresectable GIST Liver Metastases N/A
Completed NCT02917408 - Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
Recruiting NCT03773887 - Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease N/A
Recruiting NCT00345930 - DILIN's Prospective Study
Completed NCT00148031 - Improving Hepatitis C Treatment in Injection Drug Users Phase 4
Terminated NCT00031135 - Total Parenteral Nutrition-Associated Liver Disease Phase 2
Completed NCT00005305 - Hepatitis Delta Infections in Hemophiliacs N/A
Completed NCT00005304 - Delta Hepatitis and Liver Disease in Hemophiliacs
Completed NCT00222664 - Qidong Hepatitis B Intervention Study Phase 4
Recruiting NCT04551742 - Social & Contextual Impact on Children Undergoing Liver Transplantation
Completed NCT03614039 - Effect of Probiotic and Smectite Gel on NAFLD N/A
Recruiting NCT04518852 - TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC Phase 2
Enrolling by invitation NCT03396705 - Liver Regeneration
Recruiting NCT04341012 - Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases
Recruiting NCT05054712 - Prevalence of Metabolic Liver Diseases in Patients With Type 1 Diabetes Mellitus
Recruiting NCT03279419 - Thermal Imaging in Liver Disease. N/A
Active, not recruiting NCT04631965 - Healthcare Transition of Adolescents With Chronic Health Conditions
Enrolling by invitation NCT03234543 - Remote Ischemic Conditioning in Abdominal Surgery N/A
Not yet recruiting NCT04782050 - Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation N/A
Recruiting NCT04004273 - Diabetes, Exercise and Liver Fat (DELIVER) N/A